You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. An Interactive Informed Consent and Education Program for Pregnant Women

    SBC: ARCHIE MD INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Women face a variety of medical decisions during pregnancy and childbirth. While there are extensive educational resources for pregnant women, modern medicine presents decisions that many women are poorly equipped to make. Issues such as prenatal screening and mode of birth after a cesarean delivery require a significant degree of patient education to enable a ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  2. Development of Lysosomal Modulatory Drugs to Treat Alzheimer's Disease

    SBC: SYNAPTIC DYNAMICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Reducing protein deposition events is essential for slowing the progression of Alzheimer's disease (AD), especially A 1-42 peptide oligomers that accumulate inside and outside neurons and cause functional compromise. Finding a strategy to reduce A oligomeric assemblies is widely thought to be the key objective for treating AD. Accumulation of A peptides is on ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  3. Multifunctional Carriers for Systemic siRNA Delivery

    SBC: SURFAGEN, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objectives of this research project are to design and develop safe and efficient multifunctional delivery systems for systemic and target-specific delivery of small interfering RNA (siRNA) to treat human diseases with RNA interference (RNAi). RNAi is a natural mechanism for gene silencing and has a great potential to treat human disease by turning off speci ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  4. Aptamer-based Glycomics Tools

    SBC: ECHELON BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Protein glycosylation plays very important roles in biological processes. However, detecting and differentiating such modifications rapidly is not a trivial issue. Therefore, developing novel tools that allow for the rapid detection of glycosylation patterns is of tremendous importance to the field of glycomics. In this application, we propose to develop a nove ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  5. A Novel Method for Signaling Pathway Analysis

    SBC: ADVAITA CORP            Topic: N/A

    DESCRIPTION (provided by applicant): A common challenge in the analysis of genomics data is trying to understand the underlying phenomenon in the context of all complex interactions on various regulatory pathways. Currently, a statistical approach is universally used to identify the most relevant pathways in a given experiment. This approach only considers the set of genes present on each pathway ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  6. Multi-Model Detection and Quantification of Multiple Sclerosis in MR Imaging

    SBC: INFOTECH SOFT, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Multiple sclerosis (MS), a neurodegenerative disease that afflicts the central nervous system, is characterized by lesion formation and atrophy of the brain and spinal cord. Atrophy was reported to occur early in the disease and to increase with the disease progression in various cortical and sub-cortical regions, reflecting widespread loss of myelin, axons and ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  7. A chemoenzymatic technology for the efficient synthesis of novel cryptophycins

    SBC: ALLUVIUM BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The cryptophycins are a structurally diverse class of polyketide/non-ribosomal peptide natural products that possess potent anticancer activity. However, despite this impressive activity, the development of the cryptophycins into a beneficial cancer chemotherapeutic agent has suffered from clinically significant neurotoxicity that correlates with treatment. Non ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  8. PPAR-sparing/free Thiazolidinediones for Treatment of Diabetes

    SBC: Metabolic Solutions Development Company, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The overall objective of our proposed research is to discover a PPARg-free thiazolidinedione (TZD) which shows antidiabetic activity in a rodent model of Type 2 diabetes and demonstrates the necessary drug-like qualities to become a clinical candidate for human therapeutics. The insulin sensitizing agents of the TZD class are conventionally thought to operate t ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  9. Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver Disease

    SBC: Metabolic Solutions Development Company, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The overall objective of the proposed research is to discover a PPAR?-sparing thiazolidinedione (TZD) which displays efficacy in a rodent model of non-alcoholic fatty liver disease (NAFLD) and demonstrates the necessary drug-like qualities to become a potential clinical candidate for human therapeutics. The TZD class of insulin sensitizing agents are convention ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  10. Retrievable Blood Oxygen Carrier System

    SBC: NANOSHELL COMPANY, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Responding to ever increasing need for blood substitutes, scientists have developed two types of artificial oxygen carriers (AOC), polymeric hemoglobin and perfluorocarbon based AOC. While they are capable of supplying oxygen to the tissue, their side effects appear to be one of the most serious and difficult to solve problems, and a novel programmatic approach ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government